Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Devroey

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Human Reproduction (Oxford, England)|March 3, 2011
Publication bias in reproductive medicine: from the European Society of Human Reproduction and Embryology annual meeting to publicationNikolaos P Polyzos, Antonis Valachis, Evangelos Patavoukas, et al.
Fertility and Sterility|April 23, 2013
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center studyNikolaos P Polyzos, Scott M Nelson, Dominic Stoop, et al.
Fertility and Sterility|October 16, 2007
Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysisIoannis P Kosmas, Athina Tatsioni, Efstratios M Kolibianakis, et al.
Plos One|March 8, 2016
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist ProtocolGeorg Griesinger, Pierre J M Verweij, Davis Gates, et al.
Reproductive Biomedicine Online|February 3, 2012
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trialChristophe Blockeel, Sara Engels, Michel De Vos, et al.
Fertility and Sterility|February 19, 2014
Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocolHuman Mousavi Fatemi, Biljana Popovic-Todorovic, Peter Humaidan, et al.
Fertility and Sterility|August 27, 2011
Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndromeMichel De Vos, Carolina Ortega-Hrepich, Firas K Albuz, et al.
Reproductive Biomedicine Online|June 14, 2011
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian responseWilliam L Ledger, Bart C J M Fauser, Paul Devroey, et al.
Human Reproduction (Oxford, England)|May 30, 2003
An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSIPeter Platteau, Els Laurent, Carola Albano, et al.
Reproductive Biomedicine Online|December 27, 2011
Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trialJuan Antonio García-Velasco, Sanja Kupesic, Antonio Pellicer, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Human Reproduction (Oxford, England)|March 3, 2011
Publication bias in reproductive medicine: from the European Society of Human Reproduction and Embryology annual meeting to publicationNikolaos P Polyzos, Antonis Valachis, Evangelos Patavoukas, et al.
Fertility and Sterility|April 23, 2013
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center studyNikolaos P Polyzos, Scott M Nelson, Dominic Stoop, et al.
Fertility and Sterility|October 16, 2007
Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysisIoannis P Kosmas, Athina Tatsioni, Efstratios M Kolibianakis, et al.
Plos One|March 8, 2016
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist ProtocolGeorg Griesinger, Pierre J M Verweij, Davis Gates, et al.
Reproductive Biomedicine Online|February 3, 2012
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trialChristophe Blockeel, Sara Engels, Michel De Vos, et al.
Fertility and Sterility|February 19, 2014
Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocolHuman Mousavi Fatemi, Biljana Popovic-Todorovic, Peter Humaidan, et al.
Fertility and Sterility|August 27, 2011
Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndromeMichel De Vos, Carolina Ortega-Hrepich, Firas K Albuz, et al.
Reproductive Biomedicine Online|June 14, 2011
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian responseWilliam L Ledger, Bart C J M Fauser, Paul Devroey, et al.
Human Reproduction (Oxford, England)|May 30, 2003
An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSIPeter Platteau, Els Laurent, Carola Albano, et al.
Reproductive Biomedicine Online|December 27, 2011
Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trialJuan Antonio García-Velasco, Sanja Kupesic, Antonio Pellicer, et al.
Pageof 19